Retractable Technologies
About: Retractable Technologies Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession. The company's products are the VanishPoint 0.5mL insulin syringe; 1mL tuberculin, insulin, and allergy antigen syringes; 0.5mL, 1mL, 2mL, 3mL, 5mL, and 10mL syringes; the small diameter tube adapter; the blood collection tube holder; the allergy tray; the IV safety catheter; the Patient Safe syringes; the Patient Safe Luer Cap; the VanishPoint Blood Collection Set; and the EasyPoint needle, as well as a standard 3mL syringe packaged with an EasyPoint needle. The company also sells VanishPoint autodisable syringes in the international market in addition to the Company's other products.
Employees: 227
Fund manager confidence
Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)
0.37% less ownership
Funds ownership: 7.86% [Q3] → 7.49% (-0.37%) [Q4]
3% less funds holding
Funds holding: 31 [Q3] → 30 (-1) [Q4]
15% less capital invested
Capital invested by funds: $1.81M [Q3] → $1.54M (-$269K) [Q4]
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
60% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 10
Research analyst outlook
We haven’t received any recent analyst ratings for RVP.
Financial journalist opinion









